Effectiveness and Safety of Cannabidiol for Central Neurophatich Pain in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder

Real-world effectiveness and tolerability of highly purified cannabidiol in patients with monogenic developmental and epileptic encephalopathies with highly active epilepsy

Reporte# 5 Seguimiento de uso de Convupidiol en pacientes con Epilepsia refractaria (Farmacoresistente)

A Multicenter study on the use of purified cannabidiol for children with treatment – resistant developmental and epileptic encephalopathies (551 patient)

Purified cannabidiol leads to improvement of severe treatment-resistant behavioral symptoms in children with autism spectrum disorder

Expanding The Therapeutic role of highly purified cannabidiol in monogenic epilepsies : A multicenter real world study

Farmacocinetica Poblacional del Cannabidiol. Efecto de la Ingesta de alimentos y la formulación farmacéutica en la exposición sistémica en niños con encefalopatías epilépticas y del desarrollo refractarias al tratamiento

Reporte #4. Seguimiento de uso de Convupidiol® en pacientes con Epilepsia refractaria (Farmacorresistente)

Purified cannabidiol as add-on therapy in children with treatment-resistant infantile epileptic spasms syndrome

Cannabidiol purificado como terapia complementaria en niños con síndrome de espasmos epilépticos infantiles resistentes al tratamiento

Cannabidiol in children with treatment-resistant epilepsy with myoclonic-atonic seizures

Real-World Evidence of Factors Affecting Cannabidiol Exposure in Children with Drug-Resistant Developmental and Epileptic Encephalopathies